Bioelectric Medicine Market, By Product Type (Implantable cardioverter defibrillators, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, and Other bioelectric medicines), By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson’s Disease, Tremor, Depression, Epilepsy, Urinary and fecal incontinence, and Others), By End User (Hospitals, Ambulatory Care Centers, and Diagnostic Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : Jul 2019 |
  • Pages : 180 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Bioelectric Medicine Market– Insights

Bioelectric medicine has different treatment therapy that is based on electrical pulse instead of drug trigger therapy. Bioelectric medicine develops nerve stimulating and sensors activation technologies to regulate biological functions and treat diseases by combining bioengineering, neuroscience, molecular medicines, electronics, and computing. These technologies may change the future of therapies for wide range of diseases. Bioelectric medicine acts through targeted mechanism of action to treat diseases.

The global bioelectric medicine market size was valued at US$ 12.3 billion in 2017, and is expected to witness a CAGR of 7.2% over the forecast period (2019–2026).

 Global Bioelectric Medicine Market Share (%) Analysis, By Product Type, 2017

Bioelectric Medicine  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing Investment in Research & Development and Regulatory Approvals for Bioelectric Medicine Is Expected to Drive Growth of Global Bioelectric Medicine Market

Increasing approvals for bioelectric medicine products with better regulatory management by the regulatory authorities is expected to drive the global bioelectric medicine market growth during the forecast period. In March 2014, Cancer-Code Corporation (C3) announced issuance of patent which entitles: Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy, which covers an innovative approach to eradicate cancer in humans and animals.

Furthermore, increasing products approvals is expected to inhibit the growth of the market. For instance, in 2014, the U.S. FDA approved Inspire Medical Systems’ Sleep Apnea Treatment to treat sleep apnea by implanting a device that stimulates air way muscles. Furthermore, in April 2017, U.S.FDA approved a device called GammaCore launched by ElectroCore that transmits a mild electrical simulation to the vagus nerve through the skin for Migraine.

Increasing investment in development of advanced bioelectric medicines is a major factor driving growth of global bioelectric medicine market. For instance, in 2016, Medtronic Plc, a bioelectric medicine manufacturer, invested around US$ 2,224 million in the overall research and development of advanced products in bioelectric medicine

Global Bioelectric Medicine Market- Restraints

High cost attached to treatment of Parkinson’s disease may hamper growth of the global bioelectric medicine market. For instance, according to Parkinson Foundation 2018, the average cost for medications of Parkinson’s disease is US$ 2,500 and therapeutic surgery cost up to US$100,000 per person in the U.S.

Global Bioelectric Medicine Market- Regional Insights

On the basis of region, the global bioelectric medicine market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global bioelectric medicine market during the forecast period, owing to high presence of key industry players in the region including Electrocore, St. Jude Medical, and Medtronic Plc. These players are increasingly focusing on development of bioelectric medicine product. For instance, Electro Core, a U.S.-based company is working on a device to treat headaches related to migraines by stimulating vagus nerve on the neck with electrical impulses.

Asia pacific is expected to witness a rapid growth in the global bioelectric medicine market. The market in Asia Pacific is expected to gain momentum during the forecast period, owing to increasing prevalence of chronic diseases such as diabetes and hearing loss, due to rapidly increasing geriatric population in the region. For instance, according to International Diabetes Federation, in China, there were over 114,394,800 cases of diabetes in 2017. Moreover, according World Health Organization  2013, around 27.8 million Chinese people suffer from loss of hearing and 11% of people aged 60 years and above have hearing loss in China.

Global Bioelectric Medicine Market Value (US$ Bn) & Y-o-Y Growth (%), 2016-2026

   Bioelectric Medicine  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2019)

Global Bioelectric Medicine Market- Competitive Landscape

Key players operating in the global bioelectric medicine market include GlaxoSmithKline, Medtronic Plc., Boston Scientific Corporation, Liva Nova Plc, Electrocore, Nevro, and St. Jude Medical.

Bioelectric medicine is new and innovative way of treating and diagnosing diseases and injuries. All major organs in the body are connected to nerves, which allow the brain to monitor and regulate functions of all organs. Bioelectric medicine refers to the usage of a device to modulate and read the electrical activity within the body’s nervous systems. Nerve blocking devices or nerve stimulating devices that are held against the skin or implanted on a nerve have the potential to regulate specific nerve activity, make specific changes in organ function, and also restore health, without much complicated side effects of pharmaceutical agents.  

Market Dynamics

Increasing prevalence of Parkinson’s disease is expected to boost the global bioelectric medicine market growth during the forecast period. For instance, according to European Brain Council, in 2019, around 6.3 million people worldwide suffer from Parkinson’s disease and the age of onset is usually over 60 years. and  it estimated that one in ten are diagnosed before the age of 50 years, and it can affect people in their 40’s and younger. Moreover, according to Parkinson’s Foundation 2018 report, around one million people will be living with Parkinson's disease (PD) in the U.S. by 2020 and around 60,000 Americans are diagnosed with Parkinson’s disease every year.

However, high cost of devices and lack of skilled technicians to use these devices are expected to hamper growth of the global bioelectric medicine market. For instance, according to Canadian Agency for Drugs and Technologies in Health 2018, the  total operative and device costs of deep brain stimulators (per patient) is US$ 20,154 to US$ 26,043 in Canada.

Key features of the study:

  • This report provides in-depth analysis of the global bioelectric medicine market, market size (US$ Mn), and compound annual growth rate (CAGR %) during the forecast period: 2019 – 2026, considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global bioelectric medicine market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include GlaxoSmithKline, Medtronic Plc., Boston Scientific Corporation, Liva Nova Plc, Electrocore, Nevro and St. Jude Medical
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global bioelectric medicine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global bioelectric medicine market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Bioelectric Medicine Market, By Product Type:
    • Implantable cardioverter defibrillators
    • Cochlear implants
    • Spinal cord stimulators
    • Deep brain stimulators
    • Transcutaneous electrical nerve stimulators
    • Sacral nerve stimulators
    • Vagus nerve stimulators
    • Other bioelectric medicines
  • Global Bioelectric Medicine Market, By Application:
    • Arrhythmia
    • Pain management
    • Sensorineural hearing loss
    • Parkinson’s disease
    • Tremor
    • Depression
    • Epilepsy
    • Urinary and fecal incontinence
    • Others
  • Global Bioelectric Medicine Market, By End User:
    • Hospitals
    • Ambulatory Care Centres
    • Diagnostic Centers
  • Global Bioelectric Medicine Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Implantable cardioverter defibrillators
        • Cochlear implants
        • Spinal cord stimulators
        • Deep brain stimulators
        • Transcutaneous electrical nerve stimulators
        • Sacral nerve stimulators
        • Vagus nerve stimulators
        • Other bioelectric medicines
      • By Application:
        • Arrhythmia
        • Pain management
        • Sensorineural hearing loss
        • Parkinson’s disease
        • Tremor
        • Depression
        • Epilepsy
        • Urinary and fecal incontinence
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Care Centres
        • Diagnostic Centres
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type:
        • Implantable cardioverter defibrillators
        • Cochlear implants
        • Spinal cord stimulators
        • Deep brain stimulators
        • Transcutaneous electrical nerve stimulators
        • Sacral nerve stimulators
        • Vagus nerve stimulators
        • Other bioelectric medicines
      • By Application:
        • Arrhythmia
        • Pain management
        • Sensorineural hearing loss
        • Parkinson’s disease
        • Tremor
        • Depression
        • Epilepsy
        • Urinary and fecal incontinence
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Care Centres
        • Diagnostic Centres
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type:
        • Implantable cardioverter defibrillators
        • Cochlear implants
        • Spinal cord stimulators
        • Deep brain stimulators
        • Transcutaneous electrical nerve stimulators
        • Sacral nerve stimulators
        • Vagus nerve stimulators
        • Other bioelectric medicines
      • By Application:
        • Arrhythmia
        • Pain management
        • Sensorineural hearing loss
        • Parkinson’s disease
        • Tremor
        • Depression
        • Epilepsy
        • Urinary and fecal incontinence
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Care Centres
        • Diagnostic Centres
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product Type:
        • Implantable cardioverter defibrillators
        • Cochlear implants
        • Spinal cord stimulators
        • Deep brain stimulators
        • Transcutaneous electrical nerve stimulators
        • Sacral nerve stimulators
        • Vagus nerve stimulators
        • Other bioelectric medicines
      • By Application:
        • Arrhythmia
        • Pain management
        • Sensorineural hearing loss
        • Parkinson’s disease
        • Tremor
        • Depression
        • Epilepsy
        • Urinary and fecal incontinence
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Care Centres
        • Diagnostic Centres
    • Middle East
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Implantable cardioverter defibrillators
        • Cochlear implants
        • Spinal cord stimulators
        • Deep brain stimulators
        • Transcutaneous electrical nerve stimulators
        • Sacral nerve stimulators
        • Vagus nerve stimulators
        • Other bioelectric medicines
      • By Application:
        • Arrhythmia
        • Pain management
        • Sensorineural hearing loss
        • Parkinson’s disease
        • Tremor
        • Depression
        • Epilepsy
        • Urinary and fecal incontinence
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Care Centres
        • Diagnostic Centres
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type:
        • Implantable cardioverter defibrillators
        • Cochlear implants
        • Spinal cord stimulators
        • Deep brain stimulators
        • Transcutaneous electrical nerve stimulators
        • Sacral nerve stimulators
        • Vagus nerve stimulators
        • Other bioelectric medicines
      • By Application:
        • Arrhythmia
        • Pain management
        • Sensorineural hearing loss
        • Parkinson’s disease
        • Tremor
        • Depression
        • Epilepsy
        • Urinary and fecal incontinence
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Care Centres
        • Diagnostic Centres
  • Company Profiles
  • GlaxoSmithKline*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
  • Medtronic Plc.
  • Boston Scientific Corporation
  • Liva Nova Plc
  • Nevro
  • Electrocore
  • Jude Medical.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Landscape
    • Product Recall
    • Technology Overview
    • PEST Analysis
    • Porter’s Five Forces model
  4. Global Bioelectric Medicine Market, By Product Type, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Implantable cardioverter defibrillators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Cochlear implants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Spinal cord stimulators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Deep brain stimulators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Transcutaneous electrical nerve stimulators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Sacral nerve stimulators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Vagus nerve stimulators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Other bioelectric medicines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  5. Global Bioelectric Medicine Market, By Application, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Arrhythmia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Pain management
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Sensorineural hearing loss
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Parkinson’s disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Tremor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Depression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Epilepsy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Urinary and fecal incontinence
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  6. Global Bioelectric Medicine Market, By End User, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Ambulatory care centers
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Diagnostic centers
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  7. Global Bioelectric Medicine Market, By Region, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2018 – 2026, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2018 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Company Profiles
      • GlaxoSmithKline
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Medtronic Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Liva Nova Plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Electrocore
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Nevro
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • St. Jude Medical
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 38 market data tables and 27 figures on "Bioelectric Medicine Market” - Global forecast to 2026”

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.